Related Experiment Video
Updated: Jan 30, 2026
MISSION esiRNA for RNAi Screening in Mammalian Cells
Published on: May 12, 2010
High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome
Maxime Blijlevens1, Ida H van der Meulen-Muileman1, Renée X de Menezes2
1Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, de Boelelaan 1118, Amsterdam, The Netherlands.
Abstract:
Novel therapeutic strategies for non-small-cell lung cancer (NSCLC) are urgently needed. RNA splicing, orchestrated by the spliceosome, is deregulated in many forms of cancer, including NSCLC. Here, we performed high-throughput screening with a small interfering RNA library targeting all annotated human spliceosome proteins to identify cancer-selective lethal targets in the RNA splicing machinery. Silencing of several spliceosome proteins reduced cell viability in a panel of NSCLC cell lines, but not in non-malignant lung fibroblasts and epithelial cells. Interestingly, the cancer-selective lethal target set comprised all seven Sm proteins that, together with small nuclear RNA, form the core structure of most spliceosome subunits. Interfering with Sm protein expression induced apoptosis in NSCLC cells, but not in non-malignant cells. In silico analysis revealed that Sm proteins are frequently upregulated in NSCLC. For several Sm proteins, increased expression showed a positive correlation with disease severity. Together, our results suggest that the Sm proteins represent particularly useful novel targets for selective treatment of NSCLC.
Insights
Researchers identified Sm proteins as promising targets for non-small-cell lung cancer (NSCLC) therapy. Silencing these spliceosome proteins selectively killed NSCLC cells, offering a potential new treatment strategy.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- RNA splicing is crucial for cellular function and is often dysregulated in cancers like non-small-cell lung cancer (NSCLC).
- The spliceosome, the machinery responsible for RNA splicing, presents a potential target for novel cancer therapies.
Purpose of the Study:
- To identify cancer-selective lethal targets within the RNA splicing machinery for non-small-cell lung cancer (NSCLC).
- To evaluate the therapeutic potential of targeting spliceosome proteins in NSCLC treatment.
Main Methods:
- High-throughput screening of a small interfering RNA library targeting all annotated human spliceosome proteins.
- Assessing cell viability in NSCLC cell lines and non-malignant lung cells upon silencing spliceosome proteins.
- In silico analysis of Sm protein expression levels in NSCLC patient data.
Main Results:
- Silencing of several spliceosome proteins selectively reduced viability in NSCLC cells but not in non-malignant lung cells.
- The identified cancer-selective lethal targets included all seven Sm proteins, core components of the spliceosome.
- Interference with Sm protein expression induced apoptosis specifically in NSCLC cells.
- In silico analysis revealed frequent upregulation of Sm proteins in NSCLC, correlating with disease severity.
Conclusions:
- Sm proteins are frequently upregulated in NSCLC and are essential for cancer cell survival.
- Targeting Sm proteins offers a promising strategy for the selective treatment of non-small-cell lung cancer.
- Sm proteins represent novel, cancer-selective therapeutic targets for NSCLC.
Related Concept Videos
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:32RNA Splicing
02:18Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:41Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
02:15Experimental RNAi